ONCT Corporate Presentation March 2021 > ONCTERNAL > therapeutics™ TARGETING CANCER New Science. New Cancer Therapies. New Hope. Company Overview – March 2021 FORWARD LOOKING STATEMENTS This presentation includes forward-looking statements (including within the meaning of §21E of the U.S. Securities Exchange Act of 1934, as amended, and § 27A of the U.S. Securities Act of 1933, as amended). Forward looking statements, which generally include statements regarding goals, plans, intentions and expectations, ar ...

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q4 2020 Earnings Conference Call March 11, 2021 5:00 PM ET Company Participants Richard Vincent - Chief Financial Officer Jim Breitmeyer - President & Chief Executive Officer Edwina Baskin-Bey - Acting Chief Medical Officer Conference Call Participants Carl Byrnes - Northland Securities Operator Greetings, and welcome to Oncternal's Therapeutics Incorporated Fourth Quarter 2020 Financial Results Call. [Operator Instructions] As a reminder this conference is being r ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-50549 Oncternal Therapeutics, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or other jurisdiction of incorporation or organization) Delaware 62-1715807 (IRS Emp ...

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q2 2020 Earnings Conference Call August 6, 2020 5:00 PM ET Company Participants Richard Vincent – Chief Financial Officer Jim Breitmeyer – President & Chief Executive Officer Frank Hsu – Chief Medical Officer Conference Call Participants Robert Burns – H.C. Wainwright Operator Greetings, and welcome to Oncternal's Q2 Financial Results Call. [Operator Instructions] Please note that this conference call is being recorded. I will now turn the conference over to our ho ...

ONCT Corporate Presentation May 7, 2020 O O ONCTERNAL O therapeutics™ TARGETING CANCER New Science. New Cancer Therapies. New Hope. Company Overview – May 7, 2020 FORWARD LOOKING STATEMENTS This presentation includes forward-looking statements (including within the meaning of §21E of the U.S. Securities Exchange Act of 1934, as amended, and § 27A of the U.S. Securities Act of 1933, as amended). Forward looking statements, which generally include statements regarding goals, plans, intentions and expectations ...

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q1 2020 Earnings Conference Call May 7, 2020 5:00 PM ET Company Participants | --- | |---------------------------------------------------------------| | | | Richard Vincent - CFO Jim Breitmeyer - President and CEO | | Frank Hsu - Chief Medical Officer | | Conference Call Participants | | | | Hartaj Singh - Oppenheimer Carl Byrnes - Northland Securities | | Robert Burns - H.C. Wainwright | Operator Greetings, and welcome to the Oncternal Therapeutics Incorporated Fi ...

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q4 2019 Results Conference Call March 16, 2020 4:30 PM ET Company Participants | --- | |------------------------------------------------------------| | | | Richard Vincent - CFO | | Dr. Jim Breitmeyer - President and CEO | | Dr. Frank Hsu - Chief Medical Officer | | Conference Call Participants | | Hartaj Singh - Oppenheimer | | Matt Kaplan - Ladenburg Carl Byrnes - Northland Securities | Operator Greetings, ladies and gentlemen, and welcome to the Oncternal Therap ...

ONCT Corporate Presentation Piper 120519 O O ONCTERNAL Therapeutics™ TARGETING CANCER N e w S c i e n c e . N e w C a n c e r T h e r a p i e s . N e w H o p e . Piper Jaffray Healthcare Conference, December 5, 2019 FORWARD LOOKING STATEMENTS This presentation includes forward-looking statements (including within the meaning of §21E of the U.S. Securities Exchange Act of 1934, as amended, and § 27A of the U.S. Securities Act of 1933, as amended). Forward looking statements, which generally include statement ...

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q3 2019 Earnings Conference Call November 7, 2019 5:00 PM ET Company Participants Richard Vincent - Chief Financial Officer James Breitmeyer - President and Chief Executive Officer Frank Hsu - Chief Medical Officer Conference Call Participants Hartaj Singh - Oppenheimer & Company Kumar Raja - Brookline Capital Markets Operator Greetings and welcome to the Oncternal Therapeutics Third Quarter Earnings and Business Update Call. At this time, all participants are in a ...

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q2 2019 Results Earnings Conference Call August 8, 2019 5:00 PM ET Company Participants Richard Vincent - Chief Financial Officer James Breitmeyer - President and CEO Conference Call Participants Hartaj Singh - Oppenheimer Kumar Raja - Brookline Capital Market Operator Greetings. And welcome to Oncternal Therapeutics Q2 Earnings Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentatio ...